Showing results (1-10 of 75) with videos related to
Sort By:
Pageof 8
Drug Intelligence & Clinical Pharmacy|December 1, 1987
Pentoxifylline in end-stage renal diseaseM R Silver, P D KrobothClinical Pharmacology and Therapeutics|September 1, 1984
Triazolam protein binding and correlation with alpha-1 acid glycoprotein concentrationP D Kroboth, R B Smith, M I Sorkin, et al.Clinical Pharmacology and Therapeutics|April 1, 1985
Effects of end-stage renal disease and aluminum hydroxide on temazepam kineticsP D Kroboth, R B Smith, R Rault, et al.British Journal of Clinical Pharmacology|June 1, 1985
Effects of end stage renal disease and aluminium hydroxide on triazolam pharmacokineticsP D Kroboth, R B Smith, M R Silver, et al.Journal of Chromatography. B, Biomedical Sciences and Applications|November 21, 1998
Simplified procedure for measurement of serum dehydroepiandrosterone and its sulfate with gas chromatography-ion trap mass spectrometry and selected reaction monitoringM A Zemaitis, P D KrobothPsychopharmacology Bulletin|January 1, 1997
Progesterone: does it affect response to drug?P D Kroboth, J W McAuleyClinical Pharmacokinetics|June 1, 1989
Pharmacokinetics of the newer benzodiazepinesP D Garzone, P D KrobothPsychopharmacology|January 1, 1987
Influence of dosing regimen on alprazolam and metabolite serum concentrations and tolerance to sedative and psychomotor effectsR B Smith, P D KrobothDrug Intelligence & Clinical Pharmacy|July 1, 1983
New drug evaluations. TriazolamP D Kroboth, R P JuhlAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1984
Use of procainamide in chronic ambulatory peritoneal dialysis: report of a caseP D Kroboth, K Mitchum, J B PuschettPageof 8